On Rare Disease Day — a day when the international community raises awareness about rare conditions and their impact on patients’ lives — CADTH is announcing new work related to drugs for rare diseases. 

We are pleased to announce that the 2024 Symposium Travel Awards Program is now accepting applications to support attendance by individuals who could not participate in the Symposium without financial support.

Launched in 2007, the program is part of our commitment to making this important event accessible to all health care stakeholders. This year, eligible applicants can receive up to $3,000 to offset, registration, travel, food, accommodation, and other Symposium-related expenses. 

We are thrilled to share that Suzanne McGurn, President and CEO, was presented with the Public Sector Leadership Award by the Canadian Organization for Rare Disorders (CORD). The award recognizes outstanding leadership and service as a public officer over multiple years across several agencies and is presented on behalf of the rare disease community in Canada.

Last year, CADTH communicated several improvements to our drug reimbursement review program, including a Lean review to identify process enhancements. We undertook this work as part of our commitment to continuous improvement and to advance our strategic ambitions to anticipate, innovate, and transform.